In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, researchers will unveil findings that show it is not cost effective to screen for spinal muscular atrophy, the most common genetic cause of infant mortality and the second most common inherited autosomal recessive disorder.
Study finds screening for spinal muscular atrophy not cost effective
05/Feb/2010
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, researchers will unveil findings that show it is not cost effective to screen for spinal muscular atrophy, the most common genetic cause of infant mortality and the second most common inherited autosomal recessive disorder.
Link to full SMFM release on study led by MGH physician Sarah Little.

U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.